期刊
CURRENT PAIN AND HEADACHE REPORTS
卷 13, 期 3, 页码 241-248出版社
SPRINGER
DOI: 10.1007/s11916-009-0041-x
关键词
-
资金
- National Headache Foundation from Allergan Pharmaceuticals
- GlaxoSmithKline
- Merck
- Ortho-McNeil Neurologics Inc.
- Endo Pharmaceuticals
Primary headaches, including migraine and medication overuse headache (MOH), can be conceptualized as biobehavioral disorders based on the interaction of biological, psychological, and environmental factors. This article reviews empirically supported and efficacious behavioral approaches to the treatment and management of headaches in general, with an emphasis on migraine and MOH from a biopsychosocial perspective. Evidence-based behavioral medicine treatments for migraine and MOH are reviewed, including patient education, cognitive behavioral therapy, and biobehavioral training (biofeedback, relaxation training, and stress management). Information regarding psychological comorbidities and risk factors for progression of migraine and the development of MOH is also reviewed. Strategies are provided for enhancing adherence and motivation, as well as facilitating medical communication.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据